Duclos-Vallee, Jean-Charles

Publishing since 1992 (Senior)

Has published 58 publications in 18 years

Number of publications published per year by Duclos-Vallee, Jean-Charles. (Source : PubMed)

Distribution of publications types for Duclos-Vallee, Jean-Charles. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Gonzales E, Julien B, Serrière-Lanneau V, Nicou A, Doignon I, Lagoudakis L, Garcin I, Azoulay D, Duclos-Vallée JC, Castaing D, Samuel D, Hernandez-Garcia A, Awad SS, Combettes L, Thevananther S, Tordjmann T. ATP release after partial hepatectomy regulates liver regeneration in the rat.  J. Hepatol.  2010;52;1  
•  Samri A, Roque-Afonso AM, Beran O, Tateo M, Teicher E, Feray C, Sebagh M, Guettier C, Dussaix E, Vittecoq D, Samuel D, Autran B, Duclos-Vallée JC. Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).  J. Hepatol.  2009;51;6  
•  Duclos-Vallee JC, Sebagh M. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.  Liver Transpl.  2009;15 Suppl 2  
•  Teicher E, Abbara C, Duclos-Vallée JC, Antonini T, Bonhomme-Faivre L, Desbois D, Samuel D, Vittecoq D. Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation.  Liver Transpl.  2009;15;10  
•  Duclos-Vallée JC, Roche B, Samuel D. [Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus]  Presse Med  2009;38;9  
•  Trocello JM, Chappuis P, Chaine P, Rémy P, Debray D, Duclos-Vallée JC, Woimant F. [Wilson disease]  Presse Med  2009;38;7-8  
•  Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, Teicher E, Sebagh M, Roche B, Castaing D, Samuel D, Duclos-Vallee JC. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.  AIDS  2009;23;9  
•  Monsuez JJ, Carcelain G, Charniot JC, Barrière J, Duclos-Vallée JC, Parent F, Autran B. T cells subtypes in a patient with interferon-alpha induced sarcoidosis.  Am. J. Med. Sci.  2009;337;1  
•  Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.  Liver Transpl.  2008;14;12  
•  Tateo M, Sebagh M, Bralet MP, Teicher E, Azoulay D, Mallet V, Pol S, Castaing D, Samuel D, Duclos-Vallée JC. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients.  Liver Transpl.  2008;14;8  

[ See timeline ] [ See all publications ]